Prostate Cancer
Recent Abstracts
Circulating tumor extracellular vesicles to monitor metastatic prostate cancer genomics and transcriptomic evolution.
July 11, 2024
Variants in Vitamin D-related Genes and Prostate Cancer Risk in Black Men.
July 11, 2024
Social Determinants of Health Mediate Racial Disparities in Cardiovascular Disease in Men With Prostate Cancer.
July 11, 2024
A vitamin D-based strategy overcomes chemoresistance in prostate cancer.
July 11, 2024
Impact of homologous recombination repair/BReast CAncer (BRCA) gene alterations on survival in a real-world setting of metastatic prostate cancer.
July 11, 2024
Regulatory and memory T lymphocytes infiltrating prostate tumors predict long term clinical outcomes.
July 11, 2024
Longer prostate stromal cell telomere length is associated with increased risk of death from other cancers.
July 11, 2024
From Despair to Hope: First Arabic Experience of 177Lu-PSMA and 161Tb-PSMA Therapy for Metastatic Castration-Resistant Prostate Cancer.
July 11, 2024
Oral pimonidazole unveils clinicopathologic and epigenetic features of hypoxic tumour aggressiveness in localized prostate cancer.
July 11, 2024
Artificial Intelligence and Radiologists in Prostate Cancer Detection on MRI (PI-CAI): An International, Paired, Non-Inferiority, Confirmatory Study
July 10, 2024
SHP2 as a primordial epigenetic enzyme expunges histone H3 pTyr-54 to amend androgen receptor homeostasis.
July 10, 2024
Evaluating recommendation-based dietary and physical activity strategies for prostate cancer prevention: a target trial emulation in the Health Professionals Follow-up Study.
July 10, 2024
Biological determinants of PSMA expression, regulation and heterogeneity in prostate cancer.
July 10, 2024
The cost-effectiveness of germline BRCA testing in metastatic prostate cancer followed by cascade testing of first-degree relatives of mutation carriers.
July 10, 2024
Reducing Prostate Cancer Disparities for Black Men.
July 10, 2024
JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progression.
July 10, 2024
Preclinical evidence for the use of anti-Trop-2 antibody-drug conjugate Sacituzumab govitecan in cerebral metastasized castration-resistant prostate cancer.
July 10, 2024
Fluorine-18 Prostate-Specific Membrane Antigen–1007 PET/CT vs Multiparametric MRI for Locoregional Staging of Prostate Cancer
July 9, 2024
Circulating Tumor Extracellular Vesicles to Monitor Metastatic Prostate Cancer Genomics and Transcriptomic Evolution
July 9, 2024
Molecular and diffusion features for identification of clinically significant prostate cancer in PI-RADS 3 lesions.
July 9, 2024
Page 10 of 1414
Start
Prev
5
6
7
8
9
10
11
12
13
14
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free